CD40L modulates CD4+ T‐cell activation through receptor for activated C kinase 1

Author:

van Os Bram W.123ORCID,Vos Winnie G.123,Bosmans Laura A.123,van Tiel Claudia M.123,Toom Myrthe den123,Beckers Linda123,Admiraal Merel1,Hoeksema Marten A.123,de Winther Menno P.123,Lutgens Esther12345

Affiliation:

1. Department of Medical Biochemistry Amsterdam UMC location University of Amsterdam Amsterdam the Netherlands

2. Amsterdam Cardiovascular Sciences Atherosclerosis & Ischemic Syndromes Amsterdam the Netherlands

3. Amsterdam Immunity and Infection Inflammatory diseases Amsterdam the Netherlands

4. Institute for Cardiovascular Prevention (IPEK) Ludwig‐Maximilians‐Universität Munich Germany

5. German Centre for Cardiovascular Research (DZHK) partner site Munich Heart Alliance Munich Germany

Abstract

AbstractInhibition of the co‐stimulatory ligand CD40L has shown beneficial effects in many experimental models of autoimmune disease and inflammation. Here, we show that CD40L deficiency in T cells in mice causes a reduction of CD4+ T‐cell activation and specifically a strong reduction in IFN‐γ‐producing Th1 cells. In vitro, we could not reproduce this antigen presenting cell‐dependent effects, but found that T‐cell CD40L affects cell death and proliferation. We identified receptor of activated C kinase, the canonical PKC binding partner and known to drive proliferation and apoptosis, as a mediator of CD40L reverse signaling. Furthermore, we found that CD40L clustering stabilizes IFN‐γ mediated Th1 polarization through STAT1, a known binding partner of receptor of activated C kinase. Together this highlights the importance of both CD40L forward and reverse signaling.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3